Clinical trial
Epothilone in Recurrent Glioblastoma Patients
NCT00397072 · Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta, Other · Completed
Key facts
| NCT number | NCT00397072 |
|---|---|
| Title | Epothilone in Recurrent Glioblastoma Patients |
| Official title | Phase II Study: Systemic Treatment With iv ZK219477-Epothilone in Recurrent Glioblastoma Patients |
| Lead sponsor | Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta, Other |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Glioblastoma |
| Intervention type | Drug |
| Interventions | ZK 219477 |
| Enrollment | 15 |
| Start date | Jun 1, 2006 |
| Primary completion | Mar 1, 2008 |
| Completion | Dec 1, 2008 |
| First posted | Nov 8, 2006 |
| Last update posted | Apr 17, 2014 |
| Countries | Italy |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: